Boston Partners reduced its stake in W. R. Berkley Corp (NYSE:WRB) by 27.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,733,779 shares of the insurance provider’s stock after selling 1,020,838 shares during the quarter. Boston Partners owned about 2.24% of W. R. Berkley worth $202,054,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Parametrica Management Ltd bought a new position in W. R. Berkley during the third quarter valued at approximately $363,000. Pacer Advisors Inc. grew its position in W. R. Berkley by 14.6% during the third quarter. Pacer Advisors Inc. now owns 34,832 shares of the insurance provider’s stock valued at $2,784,000 after acquiring an additional 4,430 shares during the last quarter. Atria Investments LLC bought a new position in W. R. Berkley during the third quarter valued at approximately $269,000. USS Investment Management Ltd grew its position in W. R. Berkley by 3.6% during the fourth quarter. USS Investment Management Ltd now owns 140,900 shares of the insurance provider’s stock valued at $10,405,000 after acquiring an additional 4,900 shares during the last quarter. Finally, Wells Fargo & Company MN grew its position in W. R. Berkley by 3.2% during the third quarter. Wells Fargo & Company MN now owns 372,745 shares of the insurance provider’s stock valued at $29,792,000 after acquiring an additional 11,410 shares during the last quarter. 73.32% of the stock is currently owned by institutional investors and hedge funds.
Shares of W. R. Berkley stock opened at $81.96 on Wednesday. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. W. R. Berkley Corp has a 52-week low of $67.39 and a 52-week high of $82.14. The company has a market capitalization of $9.94 billion, a PE ratio of 20.44, a PEG ratio of 2.38 and a beta of 0.75.
A number of research analysts have commented on WRB shares. Zacks Investment Research cut shares of W. R. Berkley from a “hold” rating to a “sell” rating in a research report on Monday, January 21st. Morgan Stanley reduced their price target on shares of W. R. Berkley from $74.00 to $73.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 3rd. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $77.40.
COPYRIGHT VIOLATION WARNING: “W. R. Berkley Corp (WRB) Position Trimmed by Boston Partners” was originally posted by Zolmax and is the property of of Zolmax. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://zolmax.com/investing/w-r-berkley-corp-wrb-position-trimmed-by-boston-partners/2913555.html.
W. R. Berkley Company Profile
W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writer in the United States and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment underwrites commercial insurance business, including premises operations, commercial automobile, property, products liability, and professional liability lines.
Further Reading: What is the balance sheet?
Receive News & Ratings for W. R. Berkley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for W. R. Berkley and related companies with MarketBeat.com's FREE daily email newsletter.